# Benefits of Some Phytochemical Compounds in Experimental Sepsis Models: A Therapeutic Perspective

## TL;DR

This paper reviews how certain plant-based compounds may help treat sepsis by reducing inflammation and improving outcomes in experimental models.

## Contribution

The paper highlights the potential of phytochemicals as adjunct therapies for sepsis by summarizing their mechanisms and effects in experimental models.

## Key findings

- Phytochemicals show ameliorative effects in in vitro and in vivo sepsis models.
- Preemptive administration of phytochemicals can reduce inflammation and improve outcomes.
- Phytochemicals may serve as effective adjunct therapies in sepsis treatment.

## Abstract

Sepsis represents a major contributor to mortality among critically ill patients, imposing a substantial economic strain on health-care systems. The uncontrolled inflammatory response during sepsis development, often leading to multiorgan failure and death, remains a challenge despite advances in antibiotics and supportive care. Factors such as antibiotic resistance, noninfectious causes, and delays in treatment initiation contribute to the complexity of managing sepsis. This review explores alternative treatment strategies focusing on the ameliorative effects of widely consumed phytochemicals and their cellular and molecular mechanisms in various in vitro and in vivo sepsis models. Preemptive administration of phytochemicals before sepsis onset appears effective, emphasizing their potential as adjunct or complementary therapeutic agents for critically ill sepsis patients. As a consequence, phytochemicals can be included in treatment regimens to enhance overall effectiveness and expedite the healing process.